CYH Stock Forecast & Price Target

Community Health System is supported by a large, diversified footprint of 65 affiliated hospitals with 9K+ licensed beds as of 3/31/26, which gives it meaningful scale in rural and suburban markets and positions it to benefit from ongoing volume migration into larger systems. The company’s fundamentals also show tangible upside from incremental Medicaid supplemental payment approvals in Georgia, Indiana, and Florida, which contributed a $40M–$45M EBITDA benefit in 2Q and can partially offset the temporary $50M–$75M full-year ePTC headwind and softer elective procedure demand tied to weak consumer confidence. Although leverage remains elevated at 6.7x with total debt of $9.58B and full-year adjusted EBITDA guidance was lowered to $1.300B–$1.375B, the company is actively improving its balance sheet through portfolio rationalization, debt repurchases, and continued growth investments, while management’s upbeat tone on CMS developments and the Rural Health Fund adds support to the longer-term earnings recovery.

Community Health System is facing a fundamentally weaker earnings outlook because widened ePTC headwinds, persistent softness in surgical volumes, and an unfavorable payor/service mix are eroding core profitability faster than incremental Medicaid SDP benefits can offset, leading management to cut full-year adjusted EBITDA guidance to $1.300–$1.375B and acknowledge a $60–65MM 1H miss. Despite solid same-store admissions of +1.9% and adjusted admissions of +2.9% y/y, same-store net revenue per adjusted admission fell 50bp, uncompensated care rose to 32.9% of revenue, and revenues of $2.83B came in below expectations, underscoring that higher uninsured volumes and mix pressure are diluting revenue quality. The company’s large footprint of approximately 84 affiliated hospitals across 16 states provides scale, but its non-urban and medium-sized market exposure, mixed cash flow trends, and heavy leverage leave it vulnerable to a fluid operating environment where labor control and selective SDP or retroactive benefits may only partially cushion the downside.